Onconova Therapeutics (Onconova Therapeutics) PB Ratio : (As of Jun. 19, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Onconova Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-19), Onconova Therapeutics's share price is $0.0671. Onconova Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was $0.00. Hence, Onconova Therapeutics's PB Ratio of today is .

The historical rank and industry rank for Onconova Therapeutics's PB Ratio or its related term are showing as below:

ONTXW' s PB Ratio Range Over the Past 10 Years
Min: 0.4 Med: 2.37 Max: 49.25
Current: 1.83

During the past 13 years, Onconova Therapeutics's highest PB Ratio was 49.25. The lowest was 0.40. And the median was 2.37.

ONTXW's PB Ratio is ranked better than
61.69% of 1300 companies
in the Biotechnology industry
Industry Median: 2.4 vs ONTXW: 1.83

During the past 12 months, Onconova Therapeutics's average Book Value Per Share Growth Rate was -73.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 0.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -36.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Onconova Therapeutics was 0.70% per year. The lowest was -77.80% per year. And the median was -60.30% per year.

Back to Basics: PB Ratio

Onconova Therapeutics PB Ratio Historical Data

The historical data trend for Onconova Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onconova Therapeutics PB Ratio Chart

Onconova Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

Onconova Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
PB Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Onconova Therapeutics's PB Ratio

For the Biotechnology subindustry, Onconova Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onconova Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onconova Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Onconova Therapeutics's PB Ratio falls into.

Onconova Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Onconova Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2024)
	=	0.0671	/
	=

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Onconova Therapeutics (NAS:ONTXW) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Onconova Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Onconova Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Onconova Therapeutics (Onconova Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onconova Therapeutics Inc (NAS:ONTXW) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

ONTX:USA 0T2:Germany

Address

12 Penns Trail, Newtown, PA, USA, 18940

Website

https://www.onconova.com

Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab.